US7101937B1 - Dendritic based macromolecules - Google Patents

Dendritic based macromolecules Download PDF

Info

Publication number
US7101937B1
US7101937B1 US08/422,627 US42262795A US7101937B1 US 7101937 B1 US7101937 B1 US 7101937B1 US 42262795 A US42262795 A US 42262795A US 7101937 B1 US7101937 B1 US 7101937B1
Authority
US
United States
Prior art keywords
macromolecule
dendritic
polymer
linear polymer
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/422,627
Inventor
Jean M. J. Frechet
Craig J. Hawker
Karen Wooley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US08/422,627 priority Critical patent/US7101937B1/en
Application granted granted Critical
Publication of US7101937B1 publication Critical patent/US7101937B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002Dendritic macromolecules
    • C08G83/003Dendrimers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers

Definitions

  • a dendritic molecule is a highly branched polymer molecule.
  • starburst polymers The most extensive published studies of dendritic molecules are directed to “starburst” polymers. See, for example, U.S. Pat. Nos. 4,507,466; 4,558,120; 4,568,737; 4,587,329; 4,737,550; and 4,857,599. Such “starburst” polymers are made by a divergent approach building the molecule from the core towards its extremities.
  • the dendritic polymers have many uses such as polymer crosslinking agents, drug delivery systems, optoelectronic; carriers for synthetic enzymes and genetic materials, etc.
  • U.S. Pat. No. 5,041,516, at columns 5 and 6, lines 60-13 uses for dendritic polymers which include the formation of macromolecules having identifiable shapes such as “barbells”, “knots”, etc. is disclosed.
  • the disclosure is, however, very limited as to how to make such structures.
  • barbells the only disclosure of how to produce such a shape is limited to a “barbell” shape produced from 2 dendritic molecules having surface functional groups at which point they are joined together by a connecting linkage. This procedure is disclosed at col.
  • Tomalia et al U.S. Pat. No. 4,694,064 also discloses certain shaped macromolecules. Specifically, rod-shaped dendrimers are disclosed as useful shaped macromolecules. Tomalia et al U.S. Pat. Nos. 4,857,599 and 4,871,779 disclose chemical modification of dendritic arms onto a preformed polymer.
  • Shaped macromolecules may have particular uses that simple dendritic polymers do not. Accordingly, it is one of the objects of the present invention to develop novel macromolecule shapes.
  • Another object is to develop novel processes for preparing known macromolecule shapes.
  • Dendritic polymers especially those prepared by the convergent growth method as disclosed in U.S. Pat. No. 5,041,516, which is incorporated herein by reference, may be prepared with unique reactive sites located at both the focal point and at the periphery or chain ends of the molecule.
  • “Dendrimer” or “dendritic polymer” as used herein refers to any and all generations of dendritic polymers from a 1st generation wedge to a 5th or greater generation dendritic polymer. They also include dendritic wedges or fragments that are attached to a polyfunctional core through their focal points.
  • dendritic polymers produced by whatever method including “starburst” polymers such as those disclosed by Tomalia et al U.S. Pat. No. 4,857,599.
  • the reactive sites on the dendrimers may be the same or different and are available for further chemical reaction.
  • Such reactions can be designed to take place at the focal point of the dendrimer only, at the periphery only, or at both the focal point and the periphery, or at one site followed by a different reaction at the other.
  • One novel shape which may be produced according to the present invention is a “barbell” shaped macromolecule having dendritic fragments at either end of the molecule, which fragments are connected together at the focal point of each dendrimer by a suitable connecting substituent such as a linear polymer or the like.
  • “focal point” of a dendritic molecule is used to refer to the geometric location or point towards which all of the branches converge. Since a dendritic molecule is a three-dimensional “tree-like” structure by definition, the focal point is like the base of the trunk of a very regular tree, where all the branches converge.
  • Such macromolecules are different from the “barbell” shapes disclosed in U.S. Pat. No. 5,041,516 in that the only “barbell” shape specifically disclosed therein is formed by connecting two dendrimers at their outer surfaces, not at their focal points.
  • kite shaped macromolecule which generally comprises a dendritic polymer attached at its focal point to a long carbon chain group such as a linear polymer or a combination of a linear polymer and another straight chain substituent.
  • kite shaped structures may be formed by connecting such long carbon chain groups to the surface of a dendritic polymer rather than the focal point.
  • Another novel structure which may be prepared is a “triblock” structure composed of a single dendritic polymer in the center of a molecule flanked on either side by a long chain carbon substituent such as a linear polymer. Still other novel shapes are polymerized vinyl macromonomers produced by a copolymerization process of a vinyl monomer with a vinyl macromonomer.
  • the present invention also discloses a novel polymerization process for producing a “knot” shaped molecule with re-occurring dendritic polymers linked together by a repeating substituent and to a process for producing certain starburst dendrimers by a one step process.
  • Theological properties, viscosity, solubility, of the molecules will be unique.
  • the shapes of the molecules may allow their use in specialty medical and technological applications such as drug delivery agents, imaging materials, molecular devices, thin film devices, surface modifiers, transport agents, compatibilizers, rheology control agents, molecular ball bearings, molecular dipoles, non-linear optical materials, medical imaging agents, membrane and cell modifiers, complexing agents, and the like.
  • FIGS. 1 , 2 , 3 , 4 , 5 6 , 7 , 8 , 9 A, 9 B, and 9 C are pictorial representations of the reactions of Examples 1-9 respectively.
  • dendritic polymer or “dendrimer” are used herein to refer to all generations of dendritic wedges and the products obtained from attachment of dendritic wedges to core molecules.
  • dendrimer and “dendritic polymer” include macromolecules such as those of formula 1: and molecules of formula 2:
  • the second symbol represents either (i) a dendritic molecule obtained by convergent growth through attachment of several dendritic fragments or wedges to a central core, whether a complete spheroid is produced or not, or (ii) a starburst polymer.
  • the dendritic polymer may be prepared by any suitable method known in the art including the divergent approach as described in U.S. Pat. Nos. 4,289,872, 4,568,737, 4,587,329 and 4,737,550.
  • the convergent growth method is presently preferred because it permits the precise placement of both focal point and periphery functional groups which is important to the production of certain shaped macromolecules.
  • One of the novel shaped dendritic based macromolecules according to the present invention is a “kite” shaped macromolecule of the general formula 3: wherein A is a connecting group such as CH 2 , CH 2 O, COO, CONH, O, CH 2 Ph, NHCOO, NHCONH, Si(CH 3 ) 2 , CH(OH), CO, S, SO, SO 2 , SO 2 NH, CH 2 CH(Ph) 2 , CH ⁇ CH, Ph, and the like; wherein is a linear polymer such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl
  • Ph represents a phenyl group. While the A groups are written as above, they may be connected in either direction, e.g. —COO or —OCO—. These and other similarly useful families of polymers are well known in the art and are defined in textbooks such as Principles of Polymerization, third edition, by George Odian (Wiley-Interscience, 1991) or Comprehensive Polymer Science, edited by G. Allen and J. C. Bevington, Pergamon Press, 1989.
  • the “kite” shape may be represented by the general formula 4: wherein A and are as described previously.
  • Still another “kite” shape is represented by the general formula 5: wherein is a linear polymer as described previously and wherein the structure: represents a starburst dendritic polymer with multiple reactive groups X.
  • Such starburst dendritic polymers are of the type disclosed in U.S. Pat. No. 4,857,599. While six functional groups X are shown above, it is representative only and this structure may have more or less than 6 functional groups X.
  • Suitable functional groups X include NH 2 , COOCH 3 , CH 2 OH, CN, CH 2 Br, or CHO.
  • a similar “kite” shape represented by the general formula 6 can be prepared by the convergent growth approach using as the starting material a wedge structure in which the chain ends carry one or more functional groups X.
  • Suitable functional groups X include halogens, halomethyl groups such as CH 2 Br or CH 2 Cl, CN, COOH, COOCH 3 , CONH 2 , CONHCH 3 , OH, Si(CH 3 ) 3 , CH 2 OH, CHO, B(OH) 2 and the like. Examples of this type start with wedges such as Br 16 —[G-4]—Br described by K. L. Wooley et al. in Journal of the Chemical Society, Perkin Transactions I, 1991, 1059. In this formula, A is defined as it was previously.
  • Another macromolecule shape according to the present invention is a focal point connected “barbell” shape. This shape is shown by the general formula 7: wherein A and are as defined previously. The two A linkages may be the same or different.
  • Still another “barbell” shape is a starburst dendritic polymer barbell of the formula 8: wherein the structure: is as described previously, and wherein is a linear polymer as described previously or, alternatively is an aliphatic chain, a biphenyl, or other small molecule.
  • Another novel dendritic based macromolecule of the present invention is a “tri-block” shape shown by the general formula 9: wherein F 1 and F 2 are the same or different and are each selected from linear polymers such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl acetate, vinyl chloride, acrylonitrile or vinyl carbazole.
  • F 1 and F 2 are the same, the molecule is as shown in formula 9A: wherein is as recited above.
  • Still another shaped dendritic macromolecule is a vinyl macromolecule of the general formula 10: wherein n is an integer from 1 to about 1,500; wherein m is another integer from 0 to about 10,000; and wherein R 1 is a conventional vinyl monomer such as styrene, methyl methacrylate, methyl acrylate, vinyl acetate, butadiene, isoprene, and the like.
  • the novel dendritic macromolecule shapes of the present invention may be prepared according to the following general reaction schemes.
  • the kite shaped structure of formula 3 may be prepared according to Reaction Scheme I. wherein is a linear polymer as previously defined; and X and Z are groups reactive with each other to form the linking group A and may be selected from such as alcohol, carboxylic acid, acid chloride, amine, isocyanate, phenol, sulfonyl halide, aldehyde, ketone, ester, thiolate, phenolate, carbanion, alkoxide, carboxylate, Grignard reagent, boronic acid, halogen and the like.
  • Reactive groups X and Z are different and are selected for their ability to react and form a bond between the fragments that are attached to them.
  • Coupling of the dendritic and linear polymers may be achieved by a number of reactions.
  • an ester linkage may be produced (i) by the reaction of an acyl halide with. an alcohol in the presence of a catalyst such as dimethylamino pyridine, (ii) by reaction of a carboxylic acid with an alcohol at about 200° C. and high vacuum, (iii) by reaction of an acid with an alkyl halide in the presence of potassium carbonate and 18-crown6 in acetone heated at reflux, or (iv) by transesterification of an ester with an alcohol at 200° C. and high vacuum in the presence of a catalyst such as cobalt (II) acetate.
  • a catalyst such as cobalt (II) acetate
  • Amide linkages may be produced by similar reactions as for esterification, but using an amine in place of the alcohol. Reaction of an alkyl or aryl halide with an alkoxide or aroxide (Williamson) gives an ether connection.
  • a urethane or thiourethane linkage may be produced by reaction of an alcohol with an isocyanate or isothiocyanate, respectively, in the presence of a catalyst such as dibutyltin dilaurate. Alternatively, urea or thiourea connections may be achieved through coupling of an amine with an isocyanate or isothiocyanate, respectively.
  • a living polymer chain may be terminated by the dendritic polymer containing different functional groups to give the product of Scheme 1 with different chemical linkages.
  • reaction of the carbanion of living polystyrene with an acyl halide, aldehyde, isocyanate, ester, or benzylic halide located at the focal point of the dendrimer gives a kite shaped molecule with a ketone, alcohol, amide, or benzylic linkage, respectively.
  • kite shaped macromolecule of formula 4 may be prepared according to Reaction Scheme II. wherein X and Z are reactive groups as in Reaction Scheme 1 which react with each other to form linkage A.
  • the general description for the process is the same as for Scheme 1.
  • Reaction Scheme IV describes the production of the barbell shape of formula 6.
  • D 1 is a telechelic polymer (a polymer containing one reactive group at each of the two chain ends) with a reactive end-group Z at each chain end, i.e. Z Z, with X and Z defined as in General Reaction Scheme I.
  • Typical coupling reactions that can be used are as described for Scheme I. The only difference being that, since the reactions must occur at both ends of a telechelic polymer, the amount of reagents must be increased accordingly to allow two rather than one coupling to occur.
  • the starburst dendritic macromolecule barbell of formula 8 is made in a manner similar to that of the kite star dendritic macromolecule of formula 5, excepting a telechelic linear polymer is employed instead of a monofunctional polymer as the starting core with starburst growth as shown in Scheme III occurring at both ends instead of one end only.
  • Reaction Scheme VI-B may be used: wherein the linear polymers and are different from each other and may each be selected from the previous list of linear polymers.
  • Reaction Scheme VI-B shows the production of triblock structures of formula 9 wherein X 1 , X 2 , W and Z are different but selected from the same groups given for X and Z of Scheme 1. The reaction is accomplished in two steps starting with a coupling of X 1 with W
  • the second step involves coupling of X 2 with Z .
  • X 1 may be an amine, W an isocyanate, X 2 a phenol, and Z an acid chloride.
  • Z may be a boronic acid, X 2 an aryl bromide, X 1 a phenolate, and W a benzylic bromide.
  • the vinyl macromolecule of the general formula 10 is shown in Reaction Scheme VII. wherein n, m and R 1 are as described previously. Random polymerization of the two vinyl monomers is accomplished by mixing the desired proportions of the two monomers in an equal amount of solvent such as toluene or tetrahydrofuran, adding a small amount, such as 1 mole %, of a free radical initiator, such as azobisisobutyronitrile or benzoyl peroxide, stirring the mixture and heating it to 75° C. for 12 hours, cooling the mixture, then precipitating the copolymer into a suitable solvent such as hexane or methanol in which the copolymer does not dissolve.
  • a free radical initiator such as azobisisobutyronitrile or benzoyl peroxide
  • the present invention is also directed to processes for producing certain other known shaped dendritic based macromolecules.
  • One such process involves the production of a knot shaped macromolecule of the general formula 11:
  • a representative example of such a structure is as follows: The process for making such a macromolecule is shown in Reaction Scheme VIII. wherein R 2 and R 3 are different and mutually reactive and R 2 is a reactive group such as COOH, OH, COOCH 3 , CONH 2 , COO, carboxylate, NCO, halogen, or alkoxy; and wherein R 3 is a reactive group such as COOH, OH, COOCH 3 , NCO, or as listed above.
  • each X is a functional group, which may be the same or different; wherein Z is a linear polymer such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl acetate, vinyl chloride, acrylonitrile or vinyl carbazole, or styrene; X and Z are mutually reactive to form linkage A; and wherein p equals or exceeds the number that corresponds to the number of X groups.
  • the X groups are mutually reactive to form linkage A; and wherein p equals or exceeds the number that corresponds to the number of X groups.
  • reaction mixture was dissolved in tetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH 2 Cl 2 gradually increasing to 10% ether/-CH 2 Cl 2 to give the desired product 5 as a tan colored glass: yield 82%.
  • reaction mixture was dissolved in tetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH 2 Cl 2 gradually increasing to 10% ether/CH 2 Cl 2 to give the desired product 9 as a tan colored glass: yield 80%.
  • reaction mixture was added dropwise to a mixture of acetone and methanol (1:3) and processed in a standard fashion as described by Itsuno et al., Polym. J., 1991, 23, 1045) to afford the desired product 11 in 79% yield.
  • reaction mixture was dissolved intetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH 2 Cl 2 gradually increasing to 10% ether/CH 2 Cl 2 to give the desired product, 14, as a tan colored glass: yield 52%.
  • NC—[G-3]—OH 16 (2.0 g, 1.2 mmol) (prepared as in J. Chem. Soc. Perkin Trans 1 1991, 1059, Compound 26 on page 1073) in 1,4-dioxane (10 mL) was added 30% hydrogen peroxide (10 mL) and potassium hydroxide (4 g dissolved in ca. 5 mL of water). The mixture was heated at reflux and then ethanol was added until a one-phase mixture was formed (ca. 10 mL). The reaction mixture was then heated at reflux overnight, evaporated to dryness, and partitioned between chloroform and water.
  • the starting AB monomer, HOOC—[G-3]—OH 17 (1.0 g, 0.61 mmol), was homopolymerized at 200° C. and 0.6 mm Hg for 24 h.
  • the reaction mixture was dissolved in tetrahydrofuran, and precipitated into hexanes to give the title compound 18 as a tan colored glass: yield 83%.
  • the reaction was performed using high vacuum anionic polymerization techniques with break-seals using thoroughly dry equipment, solvent and reagents.
  • the polymerization of styrene carried out at ⁇ 78° C. in THF involved 0.897 g of styrene and 0.3 ml of a 0.04M solution of cumyl potassium in THF.
  • the orange-red living polystyrene 1 g that is obtained was treated under stirring with a cooled solution of 0.0495 g of [G-4]—Br 10 in THF to give a slightly yellow solution.
  • the mixture was stirred at ⁇ 30° C. for one hour then at room temperature for 10 hours.
  • the usual work-up was then carried out as follows: after addition of a small amount of methanol, the polymer was precipitated from THF into methanol to afford 91% yield of the dendrimer end-cappped polymer, 20.
  • the reaction was performed using high vacuum anionic polymerization techniques with break-seals using thoroughly dry equipment, solvent and reagents.
  • the polymerization carried out at ⁇ 78° C. in THF involved styrene monomer and a solution of a-methylstyrene tetramer in THF as initiator. This afforded a living polystyrene which is highly colored and has reactive anionic ends (both ends) 21.
  • The-final telechelic triblock copolymer (dendritic polyether-polystyrene-dendritic polyether) was obtained by adding 2 equivalents of dendritic polyether having a reactive bromide focal point (such as [G-4]—Br) to the living two-ended polystyrene 21 (the color disappears immediately as the reaction occurs).
  • the desired tri-block (dendritic polyether-polystyrene-dendritilc polyether) polymer 22 was obtained.
  • the general procedure for the synthesis of the macromonomers was as follows: to a solution of the benzylic alcohol (1.00 equivs.) in freshly distilled dry THF was added sodium hydride (60% dispersion in oil) (1.30 equivs.) and the reaction mixture stirred at room temperature under nitrogen for 30 minutes. 4-Chloromethyl styrene obtained from Eastman Kodak Co. (5.0 equiv.) in dry THF was added and the mixture heated at reflux for 18 hours. The reaction mixture was cooled, carefully, hydrolyzed, and evaporated to dryness. The residue was partitioned between water and CH 2 Cl 2 and the aqueous layer extracted with CH 2 Cl 2 (3 ⁇ ). The organic layers were then dried (Mg 2 SO 4 ) and evaporated to dryness under reduced pressure. The crude product was purified as outlined below.

Abstract

Macromolecules in the shape of three-dimensional kites, barbells, and other shapes are disclosed. The shaped macromolecules are prepared the reaction of one or more dendritic polymers and a linear polymer. The kite-shaped macromolecules are dendritic polymers attached at either their focal points or at an outer to a long carbon chain group. The barbell macromolecules have dendritic polymers at either end of the molecule, which polymers are connected together through the focal points of each by a suitable connecting substituent such as a linear polymer. The shaped macromolecules are used in specialty medical and technological applications including such as drug delivery agents, imaging materials, molecular devices, thin film devices, surface modifiers, transport agents, compatibilizers, rheology control agents, molecular ball bearings, molecular dipoles, non-linear optical materials, medical imaging agents, membrane and cell modifiers, complexing agents, adhesives, interface strengthening agents, and the like.

Description

This is a continuation of application Ser. No. 07/868,535 filed on Apr. 14, 1992, now abandoned.
BACKGROUND OF THE INVENTION
Work in the field of dendritic molecules dates back to the early fifties with the publication of a theoretical paper by Flory, J.Am. Chem. Soc., 74, 2719 (1952). Basically, a dendritic molecule is a highly branched polymer molecule.
The prior art reports various ways to prepare such dendritic molecules. For example, Vogtle and coworkers, Synthesis 155 (1978) described a “cascade” approach. This approach is not capable of producing a dendritic molecule having a molecular weight of greater than 790 Daltons. More recently, Newkome used a nucleophilic displacement reaction on a multi-functional core to produce, after two stages of reaction, a cascade molecule coined “arboral” with molecular weights of up to 1600 Daltons. See, for example, Aharoni et al, Macromolecules 15, 1093 (1982); J. Org. Chem. 50, 2004 (1985); Newkome et al. J. Chem. Soc. Chem. Commum., 752 (1986); and Newkome et al. J. Am. Chem. Soc. 108, 849 (1986).
The most extensive published studies of dendritic molecules are directed to “starburst” polymers. See, for example, U.S. Pat. Nos. 4,507,466; 4,558,120; 4,568,737; 4,587,329; 4,737,550; and 4,857,599. Such “starburst” polymers are made by a divergent approach building the molecule from the core towards its extremities.
More recently, two co-inventors of this invention obtained a patent, U.S. Pat. No. 5,041,516, describing a novel convergent approach to produce dendritic molecules. In this approach, the molecule is built from the outside towards the core. This approach enables the accurate placement of one or more functional groups in the outer surface of the dendritic polymer.
Once formed by whatever method, the dendritic polymers have many uses such as polymer crosslinking agents, drug delivery systems, optoelectronic; carriers for synthetic enzymes and genetic materials, etc. In U.S. Pat. No. 5,041,516, at columns 5 and 6, lines 60-13 uses for dendritic polymers which include the formation of macromolecules having identifiable shapes such as “barbells”, “knots”, etc. is disclosed. The disclosure is, however, very limited as to how to make such structures. For example, with respect to barbells, the only disclosure of how to produce such a shape is limited to a “barbell” shape produced from 2 dendritic molecules having surface functional groups at which point they are joined together by a connecting linkage. This procedure is disclosed at col. 6, lines 12-13, and Example VI. The only other specific disclosure relates to a “knot” structure formed by reacting a dendritic polymer having opposed COOH groups with a simple dialcohol or a polyester or polystyrene based dialcohol. This is disclosed at col. 6, lines 1-11, and in Example IX. No other specific shapes are disclosed and no other processes are disclosed to make the specifically disclosed macromolecule shapes.
Tomalia et al U.S. Pat. No. 4,694,064 also discloses certain shaped macromolecules. Specifically, rod-shaped dendrimers are disclosed as useful shaped macromolecules. Tomalia et al U.S. Pat. Nos. 4,857,599 and 4,871,779 disclose chemical modification of dendritic arms onto a preformed polymer.
Shaped macromolecules may have particular uses that simple dendritic polymers do not. Accordingly, it is one of the objects of the present invention to develop novel macromolecule shapes.
Another object is to develop novel processes for preparing known macromolecule shapes.
SUMMARY OF THE PRESENT INVENTION
Accordingly, the present invention is directed to novel dendritic based macromolecules shapes. Dendritic polymers, especially those prepared by the convergent growth method as disclosed in U.S. Pat. No. 5,041,516, which is incorporated herein by reference, may be prepared with unique reactive sites located at both the focal point and at the periphery or chain ends of the molecule. “Dendrimer” or “dendritic polymer” as used herein refers to any and all generations of dendritic polymers from a 1st generation wedge to a 5th or greater generation dendritic polymer. They also include dendritic wedges or fragments that are attached to a polyfunctional core through their focal points. They also include dendritic polymers produced by whatever method including “starburst” polymers such as those disclosed by Tomalia et al U.S. Pat. No. 4,857,599. By design, the reactive sites on the dendrimers may be the same or different and are available for further chemical reaction. Such reactions can be designed to take place at the focal point of the dendrimer only, at the periphery only, or at both the focal point and the periphery, or at one site followed by a different reaction at the other.
One novel shape which may be produced according to the present invention is a “barbell” shaped macromolecule having dendritic fragments at either end of the molecule, which fragments are connected together at the focal point of each dendrimer by a suitable connecting substituent such as a linear polymer or the like. As defined herein, “focal point” of a dendritic molecule is used to refer to the geometric location or point towards which all of the branches converge. Since a dendritic molecule is a three-dimensional “tree-like” structure by definition, the focal point is like the base of the trunk of a very regular tree, where all the branches converge. Such macromolecules are different from the “barbell” shapes disclosed in U.S. Pat. No. 5,041,516 in that the only “barbell” shape specifically disclosed therein is formed by connecting two dendrimers at their outer surfaces, not at their focal points.
Another novel shape according to the present invention is a “kite” shaped macromolecule which generally comprises a dendritic polymer attached at its focal point to a long carbon chain group such as a linear polymer or a combination of a linear polymer and another straight chain substituent. Alternatively, kite shaped structures may be formed by connecting such long carbon chain groups to the surface of a dendritic polymer rather than the focal point.
Another novel structure which may be prepared is a “triblock” structure composed of a single dendritic polymer in the center of a molecule flanked on either side by a long chain carbon substituent such as a linear polymer. Still other novel shapes are polymerized vinyl macromonomers produced by a copolymerization process of a vinyl monomer with a vinyl macromonomer.
The present invention also discloses a novel polymerization process for producing a “knot” shaped molecule with re-occurring dendritic polymers linked together by a repeating substituent and to a process for producing certain starburst dendrimers by a one step process.
Due to their unusual shapes or architectures, it is believed that the Theological properties, viscosity, solubility, of the molecules will be unique. The shapes of the molecules may allow their use in specialty medical and technological applications such as drug delivery agents, imaging materials, molecular devices, thin film devices, surface modifiers, transport agents, compatibilizers, rheology control agents, molecular ball bearings, molecular dipoles, non-linear optical materials, medical imaging agents, membrane and cell modifiers, complexing agents, and the like.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGS. 1, 2, 3, 4, 5 6, 7, 8, 9A, 9B, and 9C are pictorial representations of the reactions of Examples 1-9 respectively.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
In order to simplify the discussion of the present invention, “dendritic polymer” or “dendrimer” are used herein to refer to all generations of dendritic wedges and the products obtained from attachment of dendritic wedges to core molecules. For example, the terms “dendrimer” and “dendritic polymer” include macromolecules such as those of formula 1:
Figure US07101937-20060905-C00001
Figure US07101937-20060905-C00002

and molecules of formula 2:
Figure US07101937-20060905-C00003
They also include “starburst” polymers of U.S. Pat. No. 4,857,599, 4,507,466, 4,558,120, 4,568,737, 4,587,329 and 4,737,550, each of which is incorporated herein by reference. In describing the invention all such dendritic polymers are simply represented by the generic symbols:
Figure US07101937-20060905-C00004

These two-dimensional symbols are used to represent three-dimensional globular or spheroidal shapes. The first symbol is meant to represent a dendritic fragment or wedge with a focal point at the pointed angular end. The second symbol (circle) represents either (i) a dendritic molecule obtained by convergent growth through attachment of several dendritic fragments or wedges to a central core, whether a complete spheroid is produced or not, or (ii) a starburst polymer.
Any functional groups attached at the focal point or the periphery of the molecule will be shown as substituents attached thereto. While it is presently preferred to prepare such dendritic polymers by the convergent approach as described in U.S. Pat. No. 5,041,516, the dendritic polymer may be prepared by any suitable method known in the art including the divergent approach as described in U.S. Pat. Nos. 4,289,872, 4,568,737, 4,587,329 and 4,737,550.
The convergent growth method, however, is presently preferred because it permits the precise placement of both focal point and periphery functional groups which is important to the production of certain shaped macromolecules.
One of the novel shaped dendritic based macromolecules according to the present invention is a “kite” shaped macromolecule of the general formula 3:
Figure US07101937-20060905-C00005

wherein A is a connecting group such as CH2, CH2O, COO, CONH, O, CH2Ph, NHCOO, NHCONH, Si(CH3)2, CH(OH), CO, S, SO, SO2, SO2NH, CH2CH(Ph)2, CH═CH, Ph, and the like; wherein
Figure US07101937-20060905-P00001

is a linear polymer such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl acetate, vinyl chloride, acrylonitrile or vinyl carbazole. As used herein and throughout this application, “Ph” represents a phenyl group. While the A groups are written as above, they may be connected in either direction, e.g. —COO or —OCO—. These and other similarly useful families of polymers are well known in the art and are defined in textbooks such as Principles of Polymerization, third edition, by George Odian (Wiley-Interscience, 1991) or Comprehensive Polymer Science, edited by G. Allen and J. C. Bevington, Pergamon Press, 1989.
Alternatively, the “kite” shape may be represented by the general formula 4:
Figure US07101937-20060905-C00006

wherein A and
Figure US07101937-20060905-P00001

are as described previously.
Still another “kite” shape is represented by the general formula 5:
Figure US07101937-20060905-C00007

wherein
Figure US07101937-20060905-P00001

is a linear polymer as described previously and wherein the structure:
Figure US07101937-20060905-C00008

represents a starburst dendritic polymer with multiple reactive groups X. Such starburst dendritic polymers are of the type disclosed in U.S. Pat. No. 4,857,599. While six functional groups X are shown above, it is representative only and this structure may have more or less than 6 functional groups X. Suitable functional groups X include NH2, COOCH3, CH2OH, CN, CH2Br, or CHO.
Alternately a similar “kite” shape represented by the general formula 6:
Figure US07101937-20060905-C00009

can be prepared by the convergent growth approach using as the starting material a wedge structure in which the chain ends carry one or more functional groups X. Suitable functional groups X include halogens, halomethyl groups such as CH2Br or CH2Cl, CN, COOH, COOCH3, CONH2, CONHCH3, OH, Si(CH3)3, CH2OH, CHO, B(OH)2 and the like. Examples of this type start with wedges such as Br16—[G-4]—Br described by K. L. Wooley et al. in Journal of the Chemical Society, Perkin Transactions I, 1991, 1059. In this formula, A is defined as it was previously.
Another macromolecule shape according to the present invention is a focal point connected “barbell” shape. This shape is shown by the general formula 7:
Figure US07101937-20060905-C00010

wherein A and
Figure US07101937-20060905-P00001

are as defined previously. The two A linkages may be the same or different.
Still another “barbell” shape is a starburst dendritic polymer barbell of the formula 8:
Figure US07101937-20060905-C00011

wherein the structure:
Figure US07101937-20060905-C00012

is as described previously, and wherein
Figure US07101937-20060905-P00001

is a linear polymer as described previously or, alternatively is an aliphatic chain, a biphenyl, or other small molecule.
Another novel dendritic based macromolecule of the present invention is a “tri-block” shape shown by the general formula 9:
Figure US07101937-20060905-C00013

wherein F1 and F2 are the same or different and are each selected from linear polymers such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl acetate, vinyl chloride, acrylonitrile or vinyl carbazole. For example, when F1 and F2 are the same, the molecule is as shown in formula 9A:
Figure US07101937-20060905-C00014

wherein
Figure US07101937-20060905-P00001

is as recited above.
Still another shaped dendritic macromolecule is a vinyl macromolecule of the general formula 10:
Figure US07101937-20060905-C00015

wherein n is an integer from 1 to about 1,500; wherein m is another integer from 0 to about 10,000; and wherein R1 is a conventional vinyl monomer such as styrene, methyl methacrylate, methyl acrylate, vinyl acetate, butadiene, isoprene, and the like.
The novel dendritic macromolecule shapes of the present invention may be prepared according to the following general reaction schemes. The kite shaped structure of formula 3 may be prepared according to Reaction Scheme I.
Figure US07101937-20060905-C00016

wherein
Figure US07101937-20060905-P00001

is a linear polymer as previously defined; and X and Z are groups reactive with each other to form the linking group A and may be selected from such as alcohol, carboxylic acid, acid chloride, amine, isocyanate, phenol, sulfonyl halide, aldehyde, ketone, ester, thiolate, phenolate, carbanion, alkoxide, carboxylate, Grignard reagent, boronic acid, halogen and the like. Reactive groups X and Z are different and are selected for their ability to react and form a bond between the fragments that are attached to them. Some typical examples of coupling reactions that are well-known in the art are given below.
Coupling of the dendritic and linear polymers may be achieved by a number of reactions. For example, an ester linkage may be produced (i) by the reaction of an acyl halide with. an alcohol in the presence of a catalyst such as dimethylamino pyridine, (ii) by reaction of a carboxylic acid with an alcohol at about 200° C. and high vacuum, (iii) by reaction of an acid with an alkyl halide in the presence of potassium carbonate and 18-crown6 in acetone heated at reflux, or (iv) by transesterification of an ester with an alcohol at 200° C. and high vacuum in the presence of a catalyst such as cobalt (II) acetate. Amide linkages may be produced by similar reactions as for esterification, but using an amine in place of the alcohol. Reaction of an alkyl or aryl halide with an alkoxide or aroxide (Williamson) gives an ether connection. A urethane or thiourethane linkage may be produced by reaction of an alcohol with an isocyanate or isothiocyanate, respectively, in the presence of a catalyst such as dibutyltin dilaurate. Alternatively, urea or thiourea connections may be achieved through coupling of an amine with an isocyanate or isothiocyanate, respectively. All of these coupling reactions are well-known in the art and can be found in classical textbooks such as Advanced Organic Chemistry, 3rd edition, by Jerry March, John Wiley & Sons, 1985 or Organic Chemistry, by Peter Vollhardt, Freeman, 1987. A living polymer chain may be terminated by the dendritic polymer containing different functional groups to give the product of Scheme 1 with different chemical linkages. For example, reaction of the carbanion of living polystyrene with an acyl halide, aldehyde, isocyanate, ester, or benzylic halide located at the focal point of the dendrimer gives a kite shaped molecule with a ketone, alcohol, amide, or benzylic linkage, respectively. These reactions are described in polymer textbooks such as Polymer Synthesis, by Paul Rempp and Edward W. Merrill, Huthig und Wepf, 1986 (p. 137) or Principles of Polymerization, 3rd edition, by George Odian, John Wiley & Sons, 1991 (p. 427).
The kite shaped macromolecule of formula 4 may be prepared according to Reaction Scheme II.
Figure US07101937-20060905-C00017

wherein X and Z are reactive groups as in Reaction Scheme 1 which react with each other to form linkage A. The general description for the process is the same as for Scheme 1.
Starburst polymer kite shapes of formula 5 may be prepared according to Reaction Scheme III.
Figure US07101937-20060905-C00018

wherein X is selected from any of NH2, COOCH3, CH2OH, CN, CH2Br, and CHO, and wherein
Figure US07101937-20060905-P00001

is a linear polymer. Synthesis of a dendritic polymer by this divergent growth procedure using a linear polymer with a reactive chain end as the starting core produces a structure such as that shown in Reaction Scheme 3. Any existing divergent synthesis as described in the literature may be employed to incorporate different monomer units. For example, in Reaction Scheme 3 the reaction of an amino terminated linear polymer in which X=NH2 with (1) methyl acrylate and then (2) ethylene diamine to give a first generation dendrimer attached to the linear polymer segment. This process of sequential reactions (1) and (2) may be repeated to produce larger dendritic polymers. Each sequential set of reactions with (1) methyl acrylate and then (2) ethylene diamine gives an additional generation dendrimer.
Reaction Scheme IV describes the production of the barbell shape of formula 6.
Figure US07101937-20060905-C00019

wherein D1 is a telechelic polymer (a polymer containing one reactive group at each of the two chain ends) with a reactive end-group Z at each chain end, i.e. Z
Figure US07101937-20060905-P00001

Z, with X and Z defined as in General Reaction Scheme I. Typical coupling reactions that can be used are as described for Scheme I. The only difference being that, since the reactions must occur at both ends of a telechelic polymer, the amount of reagents must be increased accordingly to allow two rather than one coupling to occur.
The starburst dendritic macromolecule barbell of formula 8 is made in a manner similar to that of the kite star dendritic macromolecule of formula 5, excepting a telechelic linear polymer is employed instead of a monofunctional polymer as the starting core with starburst growth as shown in Scheme III occurring at both ends instead of one end only.
The triblock structure of formula 9 wherein F1 and F2 are the same are produced according to Reaction Scheme VI-A.
Figure US07101937-20060905-C00020

wherein X and Z are reactive groups as described for Scheme I, and wherein
Figure US07101937-20060905-P00001

is a linear polymer as recited previously.
Alternatively, Reaction Scheme VI-B may be used:
Figure US07101937-20060905-C00021

wherein the linear polymers
Figure US07101937-20060905-P00002

and
Figure US07101937-20060905-P00001

are different from each other and may each be selected from the previous list of linear polymers.
Reaction Scheme VI-B shows the production of triblock structures of formula 9 wherein X1, X2, W and Z are different but selected from the same groups given for X and Z of Scheme 1. The reaction is accomplished in two steps starting with a coupling of X1 with W
Figure US07101937-20060905-P00002
while X2 does not react. The second step involves coupling of X2 with Z
Figure US07101937-20060905-P00001
.
For example, X1 may be an amine, W an isocyanate, X2 a phenol, and Z an acid chloride. Alternately, Z may be a boronic acid, X2 an aryl bromide, X1 a phenolate, and W a benzylic bromide. There are numerous other possibilities for the coupling reactions, some of which are in the description after Reaction Scheme I.
The vinyl macromolecule of the general formula 10 is shown in Reaction Scheme VII.
Figure US07101937-20060905-C00022

wherein n, m and R1 are as described previously. Random polymerization of the two vinyl monomers is accomplished by mixing the desired proportions of the two monomers in an equal amount of solvent such as toluene or tetrahydrofuran, adding a small amount, such as 1 mole %, of a free radical initiator, such as azobisisobutyronitrile or benzoyl peroxide, stirring the mixture and heating it to 75° C. for 12 hours, cooling the mixture, then precipitating the copolymer into a suitable solvent such as hexane or methanol in which the copolymer does not dissolve. The copolymerization technique is well know in the art and reported in textbooks such as Preparative Methods of Polymer Chemistry, 2nd Ed., W. R. Sorenson and T. W. Campbell, Wiley Interscience 1968.
The present invention is also directed to processes for producing certain other known shaped dendritic based macromolecules. One such process involves the production of a knot shaped macromolecule of the general formula 11:
Figure US07101937-20060905-C00023

A representative example of such a structure is as follows:
Figure US07101937-20060905-C00024

The process for making such a macromolecule is shown in Reaction Scheme VIII.
Figure US07101937-20060905-C00025

wherein R2 and R3 are different and mutually reactive and R2 is a reactive group such as COOH, OH, COOCH3, CONH2, COO, carboxylate, NCO, halogen, or alkoxy; and wherein R3 is a reactive group such as COOH, OH, COOCH3, NCO, or as listed above.
Still another process for producing macromolecules according to the present invention is shown by Reaction Scheme IX, wherein star molecules produced by a one step process are synthesized.
Figure US07101937-20060905-C00026

wherein each X is a functional group, which may be the same or different; wherein Z
Figure US07101937-20060905-P00001

is a linear polymer such as polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, and other vinyl polymers derived from simple monomers such as vinyl acetate, vinyl chloride, acrylonitrile or vinyl carbazole, or styrene; X and Z are mutually reactive to form linkage A; and wherein p equals or exceeds the number that corresponds to the number of X groups. The X groups may be present in the amount shown or in lesser amounts down to about 3 and greater amounts up to about 768. Coupling occurs as described Reaction Scheme I except that a larger amount of Z is used and the reaction times are generally longer.
The following examples demonstrate the production of specific macromolecules covered by the above general formulas using specific reactions. They are only intended as examples of the various procedures which may be used to prepare the various macromolecular architectures. Variations include incorporation of different sizes of dendrimers, different structures of dendrimers, different lengths of linear chains, and different chemical structures of the linear polymer chains. All percents and parts are by weight unless otherwise specified.
EXAMPLE 1
Preparation of Peripherally Attached Poly(ethylene glycol)-Dendrimer Block Copolymers (Kite Shape, Scheme II) (FIG. 1)
A. Preparation of CN—[G-3]-OPhCH3: Compound 2
A mixture of CN—[G-3]—Br (Compound 1) (5.0 g, 3.0 mmol), p-cresol (0.39 g, 3.6 mmol), potassium carbonate (0.5 g, 3.6 mmol), and 18-crown-6 (0.15 g, 0.57 mmol) in acetone (50 mL) was heated at reflux under N2 for 12 h. Dendrimer CN—[G-3]—Br is prepared by the reaction procedure of U.S. Pat. No. 5,041,516. The specific compound is compound 27 on page 1073 of Wooley et al., J. Chem. Soc., Perkin Trans, 1, 1991, 1059. The reaction mixture was evaporated to dryness, and the residue was partitioned between methylene chloride/water. The aqueous layer was extracted with CH2Cl2 (3×25 mL) and the combined CH2Cl2 extracts were dried over MgSO4 and concentrated in vacuo. The product was purified by flash chromatography eluting with 5% hexanes/CH2Cl2 to give the title compound 2 as a colorless glass: yield 92%.
B. Preparation of HOOC—[G-3]—OPhCH3: Compound 3
To a solution of CN—[G-3]—OPhCH3 2 (1.0 g, 0.59 mmol) in 1,4-dioxane (10 mL) was added 30% hydrogen peroxide (5 mL) and potassium hydroxide (2 g dissolved in ca. 2 mL of water). The mixture was heated at reflux and then ethanol was added until a one-phase mixture was formed (ca. 4 mL). The reaction mixture was then heated at reflux overnight, cooled, acidified with glacial acetic acid, evaporated to dryness, and partitioned between chloroform and water. The aqueous layer was extracted with chloroform (3×25 mL) and the combined CHCl3 extracts were dried over MgSO4 and concentrated in vacuo. The crude product was purified by flash chromatography eluting with CH2Cl2 gradually increasing to 10% ether/CH2Cl2 to give the title compound as a colorless glass: yield 78%.
C. Preparation of C12H25(OCH2CH2)23O—[G-3]—OPhCCH3: Compound 5
Into a 25 mL round bottom flask equipped with a magnetic stir bar, hot oil bath and vacuum take-off adapter was placed HOOC—[G-3]—OPhCH3 (0.5 g, 0.3 mmol), and BrijR35 (compound 4 (C12H25(OCH2CH2)23OH, 0.7 g, 0.6 mmol), purchased from Aldrich Chemical Co. After high vacuum (0.03 mm Hg) was achieved, the reaction mixture was heated at 220° C. with stirring for 12 hours. The reaction was monitored by gel permeation chromatography. The reaction mixture was dissolved in tetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH2Cl2 gradually increasing to 10% ether/-CH2Cl2 to give the desired product 5 as a tan colored glass: yield 82%.
EXAMPLE 2
Preparation of Focal Point Attached Poly(ethylene glycol)-Dendrimer Block Copolymers via Esterification Reaction (Kite Shape, Scheme I) (FIG. 2)
A. Preparation of [G-4]—COOMe: Compound 8
A mixture of [G-3]—Br 6 (2.35 g, 1.42 mmol, 2.1 equiv.), methyl-3,5-dihydroxybenzoate (0.114 g, 0.679 mmol), potassium carbonate (0.21 g, 1.5 mmol, 2.2 equiv.) and 18-crown-6 (0.04 g, 0.15 mmol, 0.2 equiv.) in acetone was heated at reflux, under N2, for 16 h. The starting compound 6 may be prepared as shown in J. Am. Chem. Soc., 112, 1990, 7638 page 7646, compound #12. The solvent was removed under reduced pressure and the residue was partitioned between water and methylene chloride. The aqueous layer was extracted with CH2Cl2 and the combined CH2Cl2 extracts were dried over MgSO4 and evaporated to dryness. The product 8 was purified by flash chromatography eluting with CH2Cl2 to give [G-4]—COOMe as a colorless glass: yield 87%.
B. Preparation of [G-4]—COO(CH2CH2O)23C12H25: Compound 9
Into a 25 mL round bottom flask equipped with a hot oil bath, stir bar, and vacuum take-off adapter was placed [G-4]—COOMe 8 (0.5 g, 0.15 mmol), BrijR35 (C12H25(OCH2CH2)23OH, 0.45 g, 0.38 mmol, 2.5 mmol, 2.5 equiv.), and cobalt(II) acetate tetrahydrate (0.1 g. 0.4 mmol. 2.5 equiv.). After high vacuum (0.03 mm Hg) was achieved, the reaction mixture was placed into the 210° C. hot oil bath, and heated with stirring for 16 hours. The reaction was monitored by gel permeation chromatography. The reaction mixture was dissolved in tetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH2Cl2 gradually increasing to 10% ether/CH2Cl2 to give the desired product 9 as a tan colored glass: yield 80%.
EXAMPLE 3
Preparation of Focal Point Attached Poly(ethylene glycol)-Dendrimer Block Copolymers via Ether-forming Reaction (Kite Shape, Scheme I) (FIG. 3)
To a mixture of [G-4]—Br 10 (2.0 g, 0.60 mmol, 1 equiv.) (prepared as in J. Am. Chem. Soc., 1990, 112, 7638, Compound 14 at page 7646), and BrijR35 (0.60 g, 0.50 mmol, 0.8 equiv.) in THF at room temperature was added sodium hydride (0.06 g, 2.5 mmol, 4.2 equiv.). The reaction mixture was stirred at room temperature under N2. The progress of the reaction was monitored by size exclusion chromatography, which showed progressive disappearance of the starting materials. After 24 hours, the reaction mixture was added dropwise to a mixture of acetone and methanol (1:3) and processed in a standard fashion as described by Itsuno et al., Polym. J., 1991, 23, 1045) to afford the desired product 11 in 79% yield.
EXAMPLE 4
Preparation of Dendrimer-Poly(ethylene glycol)-Dendrimer Block Copolymers via Esterification Reaction (Barbell Shape, Scheme IV) (FIG. 4)
A. Preparation of [G-3]—COOMe: Compound 12
A mixture of [G-2]—Br (2.5. g. 3.1 mmol, 2.1 equiv.), methyl-3,5-dihydroxybenzoate (0.25 g, 1.5 mmol), potassium carbonate (0.45 g, 3.3 mmol, 2.2 equiv.), and 18-crown-6 (0.08 g, 0.3 mmol, 0.2 equiv.) in acetone was heated at reflux, under N2, for 16 h. The starting [G-2]—Br was prepared as shown in J. Am. Chem. Soc., 1990, 112, 7638, compound 10 page 7645. The solvent was removed under reduced pressure and the residue was partitioned between water and methylene chloride. The aqueous layer was extracted with CH2Cl2 and the combined CH2Cl2 extracts were dried over MgSO4 and evaporated to dryness. The product 12 was purified by flash chromatography eluting with CH2Cl2 to give [G-3]—COOMe as a colorless glass: yield 88%.
B. Preparation of [G-3]—CO—(OCH2CH2)46—OOC—[G-3]: Compound 14
Into a 25 mL round bottom flask equipped with a hot oil bath, stir bar, and vacuum take-off adapter was placed 12 [G-3]—COOMe (1.0 g, 0.62 mmol, 2.3 equiv.), poly(ethylene glycol) 13 (Scientific Polymer Products, Inc., narrow standard, Mw=2064, Mn=1967, 0.55 g, 0.27 mmol), and cobalt (II) acetate tetrahydrate (0.015 g, .0.06 mmol, 0.2 equiv.). After high vacuum (0.03 mm Hg) was achieved, the reaction mixture was heated at 210° C. with stirring for 16 hours. The reaction was monitored by gel permeation chromatography. The reaction mixture was dissolved intetrahydrofuran, and purified by precipitation into hexanes, precipitation into methanol and then flash chromatography eluting with CH2Cl2 gradually increasing to 10% ether/CH2Cl2 to give the desired product, 14, as a tan colored glass: yield 52%.
EXAMPLE 5
Preparation of Dendrimer-Poly(ethylene glycol)-Dendrimer Block Copolymers via Ether-forming Reaction (Barbell Shapes, Scheme IV) (FIG. 5)
A. Reaction of Telechelic Hydroxy Terminated Polyethylene Glycol with [G-3]—Br
A reaction of telechelic hydroxy terminated polyethylene glycol with [G-3]—Br 6, Polyethylene glycol (PEG) 13 terminated at both ends with hydroxyl groups and having narrow molecular weight distribution (<1.08) with molecular weight 3,000 was used. 0.31 g PEG dissolved in tetrahydrofuran was treated with 0.01 g of sodium hydride and 0.29 g of ether-linked [G-3]—Br. The reaction mixture was stirred at 65° C. for 65 hrs under inert atmosphere. The reaction mixture was poured in acetone and the liquid phase concentrated, then precipitated into hexanes. The product 15 was separated by chromatography to afford 63% of the desired.polyethylene glycol terminated with [G-3] at both ends 15.
B. Reaction of Telechelic Hydroxy Terminated Polyethylene Glycol with [G-4]—Br.
Polyethylene glycol (PEG) terminated at both ends with hydroxyl groups and having narrow molecular, weight distribution (<1.05) with a molecular weight 11,000 was used in a repeat of the above. The procedure was as described above except that ether linked [G-4]—Br was used. The yield of purified product was 69%.
EXAMPLE 6
Preparation of Dendrimer Homopolymers by Step-Growth Polymerization (Knot Shape, Scheme VIII) (FIG. 6)
A. Preparation of HOOC—[G-3]—OH: Compound 17
To a solution of NC—[G-3]—OH 16 (2.0 g, 1.2 mmol) (prepared as in J. Chem. Soc. Perkin Trans 1 1991, 1059, Compound 26 on page 1073) in 1,4-dioxane (10 mL) was added 30% hydrogen peroxide (10 mL) and potassium hydroxide (4 g dissolved in ca. 5 mL of water). The mixture was heated at reflux and then ethanol was added until a one-phase mixture was formed (ca. 10 mL). The reaction mixture was then heated at reflux overnight, evaporated to dryness, and partitioned between chloroform and water. The aqueous layer was extracted with chloroform (3×25 mL) and the combined CHCl3 extracts were dried over MgSO4 and concentrated. The crude product was purified by flash chromatography eluting with CH2Cl2 gradually increasing to 10% ether/CH2Cl2 to give the title compound 17 as a colorless glass: yield 84%.
B. Preparation of —(—OC—[G-3]—O—)n: Compound 18
The starting AB monomer, HOOC—[G-3]—OH 17 (1.0 g, 0.61 mmol), was homopolymerized at 200° C. and 0.6 mm Hg for 24 h. The reaction mixture was dissolved in tetrahydrofuran, and precipitated into hexanes to give the title compound 18 as a tan colored glass: yield 83%. Mw=430,000, Mn=180,000.
EXAMPLE 7
Preparation of Dendrimer-Terminated Vinyl Polymer: Compound 20 (Kite Shape, Scheme I) (FIG. 7)
The reaction was performed using high vacuum anionic polymerization techniques with break-seals using thoroughly dry equipment, solvent and reagents. The polymerization of styrene carried out at −78° C. in THF involved 0.897 g of styrene and 0.3 ml of a 0.04M solution of cumyl potassium in THF. The orange-red living polystyrene 1 g that is obtained was treated under stirring with a cooled solution of 0.0495 g of [G-4]—Br 10 in THF to give a slightly yellow solution. The mixture was stirred at −30° C. for one hour then at room temperature for 10 hours. The usual work-up was then carried out as follows: after addition of a small amount of methanol, the polymer was precipitated from THF into methanol to afford 91% yield of the dendrimer end-cappped polymer, 20.
EXAMPLE 8
Preparation of Telechelic Dendrimer-Terminated Vinyl Polymer: Compound 22 (Barbell Shape, Scheme IV) (FIG. 8)
The reaction was performed using high vacuum anionic polymerization techniques with break-seals using thoroughly dry equipment, solvent and reagents. The polymerization carried out at −78° C. in THF involved styrene monomer and a solution of a-methylstyrene tetramer in THF as initiator. This afforded a living polystyrene which is highly colored and has reactive anionic ends (both ends) 21. The-final telechelic triblock copolymer (dendritic polyether-polystyrene-dendritic polyether) was obtained by adding 2 equivalents of dendritic polyether having a reactive bromide focal point (such as [G-4]—Br) to the living two-ended polystyrene 21 (the color disappears immediately as the reaction occurs). After the usual work up as described in Example 7 (addition of a small amount of methanol and precipitation from THF into methanol), the desired tri-block (dendritic polyether-polystyrene-dendritilc polyether) polymer 22 was obtained.
EXAMPLE 9
Preparation of Dendritic Copolymers Using Dendritic Vinyl Macromonomer with Vinyl Monomer (Scheme VII) (FIGS. 9A, 9B, and 9C)
The general procedure for the synthesis of the macromonomers was as follows: to a solution of the benzylic alcohol (1.00 equivs.) in freshly distilled dry THF was added sodium hydride (60% dispersion in oil) (1.30 equivs.) and the reaction mixture stirred at room temperature under nitrogen for 30 minutes. 4-Chloromethyl styrene obtained from Eastman Kodak Co. (5.0 equiv.) in dry THF was added and the mixture heated at reflux for 18 hours. The reaction mixture was cooled, carefully, hydrolyzed, and evaporated to dryness. The residue was partitioned between water and CH2Cl2 and the aqueous layer extracted with CH2Cl2 (3×). The organic layers were then dried (Mg2SO4) and evaporated to dryness under reduced pressure. The crude product was purified as outlined below.
The starting materials [G-3]—OH, [G-4]—OH, and [G-5]—OH are all reported by C. J. Hawker, J. M. J. Frechet, J. Am. Chem. Soc., 1990, 112, 7638. [G-3]—OH is compound 11 page 7645, [G-4]—OH is compound 13 page 7646, and [G-5]—OH is compound 15 page 7646.
A. Preparation of [G-3]-styrene: Compound 24
This was prepared from [G-3]—OH 23 and purified by flash chromatography eluting with 2:3 hexane/CH2Cl2 gradually increasing to CH2Cl2 to give 7 as a colorless glass: yield 77%; (Found: C, 79,98; H, 6.03. C114H100O15 requires C, 80.07; H, 5.89%).
B. Preparation of [G-4]-styrene: Compound 26
This was prepared from [G-4]—OH 25 and purified by flash chromatography eluting with 1:3 hexane/CH2Cl2 gradually increasing to CH2Cl2 to give 26 as a colorless glass: yield 73%; (Found: C, 79.58; H. 5.95, C226H196O31 requires C, 79.65; H, 5.80%).
C. Preparation of [G-5]-styrene: Compound 28
This was prepared from [G-5]—OH 27 and purified by flash chromatography eluting with 1:3 hexane/CH2Cl2 gradually increasing to CH2Cl2 to give 28 as a colorless glass: yield 67%; (Found: C, 79.35; H, 6.00. C4500H388O63 requires C, 79.44; H, 5.75%).
D. Copolymerization of the Macromonomers with Styrene
All the copolymerizations were carried out as described below for a 1:4 mixture (by weight) of [G-3]-styrene with styrene.
To the 3rd generation macromonomer 24 (600 mg, 0.35 mmol) was added freshly distilled styrene (2.40 g, 23.1 mmol), AIBN (40 mg, 0.24 mmol, 1.0 mol percent), freshly distilled and degassed toluene (2.50 g) and the solution heated at 70-75° C. under argon for 26 hours. The reaction mixture was then precipitated into hexane, the precipitated solid collected and reprecipitated into 1:3 isopropanol/acetone. The purified product was then reprecipitated into methanol and the white solid collected by filtration: yield 64%.
All other copolymerization were carried out using a similar procedure, feed ratios, yields, and molecular weight data (polystyrene standards) are shown in Table 1.
TABLE 1
Copolymers of Dendritic Macromonomers with Styrene
Macromonomer,
Macromonomer wt % Yield Copolymer
Generation Structure feed prod. % Mw Mn
[G-3] 24 1.0 1.0 76 42000 28000
[G-3] 24 3.0 3.2 72 44000 31000
[G-4] 26 3.0 3.1 69 40000 27000
[G-5] 28 3.0 2.9 68 45000 34000
[G-3] 24 20.0  21.0  64 49000 35000
[G-4] 26 20.0  20.7  62 53000 37000
[G-5] 28 20.0  19.6  61 50000 34000
[G-3] 24 30.0  31.3  59 71000 46000
[G-3] 24 40.0  41.3  52 79000 48000

Claims (15)

1. A macromolecule composed of a single dendritic polymer having a focal point and a linear polymer, said macromolecule having the shape of a three-dimensional kite and represented by the formula 3:
Figure US07101937-20060905-C00027
wherein
Figure US07101937-20060905-P00001
represents a linear polymer which is absent from the dendritic polymer and is bonded to the focal point of the dendritic polymer through a connecting group A.
2. The macromolecule of claim 1 wherein A is selected from any of CH2, CH2O, COO, CONH, O, CH2Ph, NHCOO, NHCONH, Si(CH3)2, CH(OH), CO, S, SO, SO2, SO2NH, CH2CH(Ph)2, CH2CH(Ph)CH2, CH═CH, or Ph.
3. The macromolecule of claim 1 wherein the linear polymer is selected from any of polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, poly(vinyl acetate), poly(vinyl chloride), polyacrylonitrile or poly(vinyl carbazole).
4. The macromolecule of claim 1, wherein the linear polymer is polyethylene glycol and A is COO.
5. The macromolecule of claim 1, wherein the linear polymer is polyethlene glycol and A is CH2O.
6. The macromolecule of claim 1, wherein the linear polymer is polystyrene and A is CH2CH(Ph)CH2.
7. A macromolecule composed of a single dendritic polymer having a periphery functional group and a linear polymer, said macromolecule having the shape of a three-dimensional kite and represented by formula 4:
Figure US07101937-20060905-C00028
wherein A is a connecting group and
Figure US07101937-20060905-P00001
is a linear polymer which is absent in the dendritic polymer and is bonded to the dendritic polymer through the periphery functional group.
8. The macromolecule of claim 7 wherein A is selected from any of CH2, CH2O, COO, CONH, O, CH2Ph, NHCOO, NHCONH, Si(CH3)2, CH(OH), CO, S, SO, SO2, SO2NH, CH2CH(Ph)2, CH2CH(Ph)CH2, CH═CH, or Ph.
9. The macromolecule of claim 7 wherein the linear polymer is selected from any of polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, poly(vinyl acetate), poly(vinyl chloride), polyacrylonitrile or poly(vinyl carbazole).
10. The macromolecule of claim 6, wherein the linear polymer is polyethylene glycol and A is COO.
11. A macromolecule composed of two dendritic polymers having the shape of a barbell and represented by the general formula:
Figure US07101937-20060905-C00029
wherein A is a connecting group and wherein
Figure US07101937-20060905-P00001
is a linear polymer which is bonded to a focal group in each of the two dendritic polymers.
12. The macromolecule of claim 11 wherein each A is selected from any of CH2, CH2O, COO, CONH, O, CH2Ph, NHCOO, NHCONH, Si(CH3)2, CH(OH), CO, S, SO, SO2, SO2NH, CH2CH(Ph)2, CH2CH(Ph)CH2, CH═CH, or Ph.
13. The macromolecule of claim 11 wherein the linear polymer is selected from any of polystyrene, polycarbonate, polyester, polyamide, polycarbonate, polyolefin, polyethylene glycol, polyacrylate, polymethacrylate, polysulfone, polyetherketone, polyacetal, polyether, polythioether, polyoxazoline, polyphosphazene, polysiloxane, polyanhydride, polyurethane, polyphenylene, polysaccharide, poly(vinyl acetate), poly(vinyl chloride), polyacrylonitrile or poly(vinyl carbazole).
14. The macromolecule of claim 11, wherein A is COO and wherein the linear polymer is polyethylene glycol.
15. The macromolecule of claim 11, wherein A is CH2O and the linear polymer is polyethylene glycol.
US08/422,627 1992-04-14 1995-04-14 Dendritic based macromolecules Expired - Fee Related US7101937B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/422,627 US7101937B1 (en) 1992-04-14 1995-04-14 Dendritic based macromolecules

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86853592A 1992-04-14 1992-04-14
US08/422,627 US7101937B1 (en) 1992-04-14 1995-04-14 Dendritic based macromolecules

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US86853592A Continuation 1992-04-14 1992-04-14

Publications (1)

Publication Number Publication Date
US7101937B1 true US7101937B1 (en) 2006-09-05

Family

ID=25351881

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/422,627 Expired - Fee Related US7101937B1 (en) 1992-04-14 1995-04-14 Dendritic based macromolecules

Country Status (7)

Country Link
US (1) US7101937B1 (en)
EP (1) EP0636156B1 (en)
JP (1) JPH07505915A (en)
AT (1) ATE156158T1 (en)
CA (1) CA2118130A1 (en)
DE (1) DE69312700T2 (en)
WO (1) WO1993021259A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100181257A1 (en) * 2008-10-03 2010-07-22 Jean Frechet Extraction Of Anions From Solutions And Mixtures Using Hyperbranched Macromolecules
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
US20150118624A1 (en) * 2013-10-24 2015-04-30 Az Electronic Materials (Luxembourg) S.A.R.L. Composition for forming resist underlayer
US9045579B2 (en) 2012-03-13 2015-06-02 California Institute Of Technology Periodic nanostructures from self assembled wedge-type block-copolymers
US9249275B2 (en) 2009-07-01 2016-02-02 Japan Science And Technology Agency Polyionic dendrimer and hydrogel comprising same
US9382387B2 (en) 2012-03-13 2016-07-05 California Institute Of Technology Rapid self-assembly of block copolymers to photonic crystals
US9453943B2 (en) 2012-06-28 2016-09-27 California Institute Of Technology Photonic structures from self assembly of brush block copolymers and polymer blends
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
US10153513B2 (en) 2015-03-09 2018-12-11 California Institute Of Technology Triblock brush block copolymers
US11053356B2 (en) 2017-03-07 2021-07-06 California Institute Of Technology Control of polymer architectures by living ring-opening metathesis copolymerization

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9504664A (en) * 1994-03-07 1997-05-31 Dow Chemical Co Bioactive and/or targeted dendrimer conjugates.
BE1008134A3 (en) * 1994-03-16 1996-01-23 Dsm Nv Preparation of star-branched polymers.
GB9421282D0 (en) * 1994-10-21 1994-12-07 Exxon Chemical Patents Inc Additives and oleaginous compositions
US5561214A (en) * 1995-05-18 1996-10-01 Bayer Corporation Hyperbranched polyaspartate esters and a process for their preparation
US5830986A (en) * 1996-10-28 1998-11-03 Massachusetts Institute Of Technology Methods for the synthesis of functionalizable poly(ethylene oxide) star macromolecules
US6255424B1 (en) 1997-11-25 2001-07-03 Colorado School Of Mines Dendritic polymers and convergent method of synthesis
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
DE69934425T2 (en) 1998-10-23 2007-09-27 Amgen Inc., Thousand Oaks THROMBOPOIETIN SUBSTITUTE
JP3181276B2 (en) 1999-08-31 2001-07-03 科学技術振興事業団 Amphiphilic compounds with dendritic branch structure
AU4830901A (en) 2000-02-09 2001-08-20 Ciba Specialty Chemicals Holding Inc. Hyperbranched amphiphilic polymeric additives and polymer compositions with increased surface energy
WO2001081376A2 (en) 2000-04-21 2001-11-01 Amgen Inc. Apo-ai/aii peptide derivatives
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US6677136B2 (en) 2000-05-03 2004-01-13 Amgen Inc. Glucagon antagonists
CA2408617A1 (en) 2000-05-12 2001-11-22 Amgen Inc. Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
US6407169B1 (en) * 2000-12-13 2002-06-18 The University Of Waterloo Method for synthesis of graft polymers
JP4511075B2 (en) * 2001-04-23 2010-07-28 レンゴー株式会社 Sulfur-containing urethane dendrimer and method for producing the same
EE05294B1 (en) 2001-05-11 2010-04-15 Amgen Inc. TALL-1 binding agent composition
DK1387862T3 (en) 2001-05-17 2015-01-19 Basf Se Polymer WITH IMPROVED permanence AND OVERFLADEAFFINITET
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7332474B2 (en) 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
JP3984541B2 (en) * 2001-12-26 2007-10-03 財団法人川村理化学研究所 Particles comprising star-shaped polyoxazoline and method for producing the same
SG143252A1 (en) 2003-10-09 2008-06-27 Ambrx Inc Polymer derivatives
CA2543484C (en) 2003-10-27 2014-02-04 Amgen Inc. Modulation of immune response to an immunogen with ctla-4 and tnfbp
NZ586034A (en) 2004-02-02 2011-10-28 Ambrx Inc Modified human growth hormone polypeptides and their uses
ES2605792T3 (en) 2004-05-13 2017-03-16 Icos Corporation Quinazolinone used as a human phosphatidylinositol 3-kinase delta inhibitor
US7632924B2 (en) 2004-06-18 2009-12-15 Ambrx, Inc. Antigen-binding polypeptides and their uses
MX2007000216A (en) 2004-07-08 2007-03-15 Amgen Inc Therapeutic peptides.
JP4421614B2 (en) * 2004-08-13 2010-02-24 日本曹達株式会社 Star polymer, acid-decomposable resin composition, resist composition and di (meth) acrylate compound
CA2594557C (en) 2004-12-22 2016-04-26 Ambrx, Inc. Modified human growth hormone
JP2008525032A (en) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド Methods for expressing and purifying recombinant human growth hormone
US7736872B2 (en) 2004-12-22 2010-06-15 Ambrx, Inc. Compositions of aminoacyl-TRNA synthetase and uses thereof
WO2006069246A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
KR101224781B1 (en) 2004-12-22 2013-01-21 암브룩스, 인코포레이티드 Formulations of human growth hormone comprising a non-naturally encoded amino acid
US9487631B2 (en) 2005-05-21 2016-11-08 University Of Durham Surface active polymeric systems
JP2008541769A (en) 2005-06-03 2008-11-27 アンブレツクス・インコーポレイテツド Improved human interferon molecules and their use
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
JP5905184B2 (en) 2005-10-13 2016-04-20 ヒューマン ジノーム サイエンシーズ, インコーポレイテッドHuman Genome Sciences, Inc. Methods and compositions for use in treating patients with autoantibody positive disease
ES2625109T3 (en) 2005-10-25 2017-07-18 Starpharma Pty Limited Macromolecular compounds that have controlled stoichiometry
PE20070684A1 (en) 2005-11-14 2007-08-06 Amgen Inc RANKL-PTH / PTHrP ANTIBODY CHEMERICAL MOLECULES
CN101454461A (en) 2005-11-16 2009-06-10 Ambrx公司 Methods and compositions comprising non-natural amino acids
US9012605B2 (en) 2006-01-23 2015-04-21 Amgen Inc. Crystalline polypeptides
US8293500B2 (en) 2006-03-22 2012-10-23 Viral Logic Systems Technology Corp. Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
US8129334B2 (en) 2006-03-31 2012-03-06 The Regents Of The University Of California Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
US8377448B2 (en) 2006-05-15 2013-02-19 The Board Of Trustees Of The Leland Standford Junior University CD47 related compositions and methods for treating immunological diseases and disorders
US7981425B2 (en) 2006-06-19 2011-07-19 Amgen Inc. Thrombopoietic compounds
EP2452683A3 (en) 2006-06-26 2012-08-22 Amgen Inc. Methods for treating atherosclerosis
US20080020043A1 (en) * 2006-07-20 2008-01-24 Marc Gingras Dendrimer-Drug Conjugates
DK2061878T3 (en) 2006-09-08 2014-04-07 Ambrx Inc HYBRID SUPPRESSOR TRNA FOR ANIMAL CELLS
JP5840345B2 (en) 2006-09-08 2016-01-06 アンブルックス, インコーポレイテッドAmbrx, Inc. Modified human plasma polypeptides or modified human Fc scaffold proteins and uses thereof
MX2009002526A (en) 2006-09-08 2009-04-16 Ambrx Inc Suppressor trna transcription in vertebrate cells.
EP2097422A4 (en) 2006-11-13 2010-04-14 Lilly Co Eli Thienopyrimidinones for treatment of inflammatory disorders and cancers
US8507200B2 (en) 2007-02-09 2013-08-13 Northwestern University Particles for detecting intracellular targets
JP5288363B2 (en) * 2007-02-16 2013-09-11 国立大学法人九州大学 Compound having liquid dendron and mesogen, liquid crystal composition and optical device
KR101476472B1 (en) 2007-03-30 2015-01-05 암브룩스, 인코포레이티드 Modified fgf-21 polypeptides and their uses
NZ580686A (en) 2007-05-02 2012-11-30 Ambrx Inc Modified interferon beta polypeptides and their uses
WO2008151049A2 (en) 2007-05-30 2008-12-11 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
SI2489731T1 (en) 2007-07-26 2014-12-31 Amgen Inc. Patent Operations, M/S 28-2-C Modified lecithin-cholesterol acyltransferase enzymes
AU2008326324B9 (en) 2007-11-20 2012-11-15 Ambrx, Inc. Modified insulin polypeptides and their uses
US9938333B2 (en) 2008-02-08 2018-04-10 Ambrx, Inc. Modified leptin polypeptides and their uses
CA2729012A1 (en) 2008-06-27 2009-12-30 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010002895A2 (en) 2008-06-30 2010-01-07 The Regents Of The University Of Michigan Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
ES2963062T3 (en) 2008-07-23 2024-03-25 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
BRPI0919403A2 (en) 2008-09-26 2017-09-26 Ambrx Inc modified animal erythropoietin polypeptides and their uses
NZ592249A (en) 2008-09-26 2013-03-28 Ambrx Inc Non-natural amino acid replication-dependent microorganisms and vaccines
NZ592880A (en) 2008-11-13 2013-06-28 Gilead Calistoga Llc Combinations of purine derivatives and proteasome inhibitors such as bortezomib for the treatment of hematological malignancy
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
MX2011005429A (en) 2008-11-24 2011-06-21 Univ Northwestern Polyvalent rna-nanoparticle compositions.
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA2756347A1 (en) 2009-03-24 2010-09-30 Gilead Calistoga Llc Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
WO2010123931A1 (en) 2009-04-20 2010-10-28 Calistoga Pharmaceuticals Inc. Methods of treatment for solid tumors
RU2012101779A (en) 2009-06-19 2013-07-27 МЕДИММЬЮН, ЭлЭлСи PROSTHETIC OPTIONS
JP2013500257A (en) 2009-07-21 2013-01-07 ギリアード カリストガ エルエルシー Treatment of liver damage with PI3K inhibitors
US20120183546A1 (en) 2009-09-23 2012-07-19 Amgen Inc. Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
WO2011049625A1 (en) 2009-10-20 2011-04-28 Mansour Samadpour Method for aflatoxin screening of products
EP2494075B1 (en) 2009-10-30 2018-04-04 Northwestern University Templated nanoconjugates
LT2496567T (en) 2009-11-05 2017-11-27 Rhizen Pharmaceuticals S.A. Novel benzopyran kinase modulators
CN104017063A (en) 2009-12-21 2014-09-03 Ambrx公司 Modified porcine somatotropin polypeptides and their uses
CN107674121A (en) 2009-12-21 2018-02-09 Ambrx 公司 Bovine somatotropin polypeptide and its purposes by modification
ES2460944T3 (en) * 2010-01-20 2014-05-16 Basf Se Process for the preparation of an aqueous polymer dispersion
JP2013528599A (en) 2010-05-14 2013-07-11 アムジェン インコーポレイテッド Enhanced death receptor agonist
CN103068824B (en) 2010-05-17 2017-09-08 印蔻真治疗公司 It is used as new 3,5 2 substitution 3H imidazos [4,5 B] pyridine and 3,5 2 substitution 3H [1,2,3] triazol [4,5 B] pyridine compounds of protein kinase modulators
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
EP2605789B1 (en) 2010-08-17 2019-06-05 Ambrx, Inc. Modified relaxin polypeptides and their uses
AR083006A1 (en) 2010-09-23 2013-01-23 Lilly Co Eli FORMULATIONS FOR THE STIMULATING FACTOR OF COLONIES OF GRANULOCITS (G-CSF) BOVINE AND VARIANTS OF THE SAME
RS58326B1 (en) 2011-05-04 2019-03-29 Rhizen Pharmaceuticals S A Novel compounds as modulators of protein kinases
CA2847698C (en) 2011-09-14 2020-09-01 Northwestern University Nanoconjugates able to cross the blood-brain barrier
AP2014007875A0 (en) 2012-03-05 2014-08-31 Gilead Calistoga Llc Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
EP2831116A1 (en) 2012-03-28 2015-02-04 Amgen Inc. Dr5 receptor agonist combinations
MX359888B (en) 2012-03-30 2018-10-15 Rhizen Pharmaceuticals Sa Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinases.
US9738724B2 (en) 2012-06-08 2017-08-22 Sutro Biopharma, Inc. Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
EP2863955B1 (en) 2012-06-26 2016-11-23 Sutro Biopharma, Inc. Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
DK2877490T3 (en) 2012-06-27 2018-12-17 Univ Princeton SPLIT INTEINS, CONJUGATES AND APPLICATIONS THEREOF
SI3584255T1 (en) 2012-08-31 2022-05-31 Sutro Biopharma, Inc Modified amino acids comprising an azido group
US9272075B2 (en) 2013-02-04 2016-03-01 W.L. Gore & Associates, Inc. Coating for substrate
KR102247959B1 (en) 2013-02-04 2021-05-06 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 Coating for substrate
ES2658039T3 (en) 2013-07-10 2018-03-08 Sutro Biopharma, Inc. Antibodies comprising multiple site-specific non-natural amino acid residues, methods for their preparation and methods of use
WO2015054658A1 (en) 2013-10-11 2015-04-16 Sutro Biopharma, Inc. Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
MX2016008259A (en) 2013-12-20 2016-10-13 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors.
US9708327B2 (en) 2013-12-20 2017-07-18 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
MX2016016530A (en) 2014-06-13 2017-03-27 Gilead Sciences Inc Phosphatidylinositol 3-kinase inhibitors.
KR20240024362A (en) 2014-10-24 2024-02-23 브리스톨-마이어스 스큅 컴퍼니 Modified fgf-21 polypeptides and uses thereof
CA2968310A1 (en) 2014-11-19 2016-05-26 NZP UK Limited 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
JP6700274B2 (en) 2014-11-19 2020-05-27 エヌゼットピー ユーケー リミテッド 6-Alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the preparation of steroid FXR modulators
EA034739B1 (en) 2014-11-19 2020-03-16 ЭнЗедПи ЮКей ЛИМИТЕД 6-alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal fxr modulators
EP3221332B1 (en) 2014-11-19 2019-04-24 NZP UK Limited 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
CN107106493A (en) 2014-11-21 2017-08-29 西北大学 The sequence-specific cellular uptake of spherical nucleic acid nano particle conjugate
US20170157215A1 (en) 2015-12-04 2017-06-08 Jomoco, Corp. Compositions and methods to mitigate or prevent an immune response to an immunogenic therapeutic molecule in non-human primates
CA3011455A1 (en) 2016-01-27 2017-08-03 Sutro Biopharma, Inc. Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
MX2019008449A (en) 2017-02-08 2019-09-09 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof.
JP6844773B2 (en) * 2017-03-01 2021-03-17 国立大学法人 岡山大学 Boron-containing dendrimer with intracellular transfer function
EP3658588A1 (en) 2017-07-26 2020-06-03 Sutro Biopharma, Inc. Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma
KR20200051802A (en) 2017-09-18 2020-05-13 서트로 바이오파마, 인크. Anti-folate receptor alpha antibody conjugates and uses thereof
SG11202102427XA (en) 2018-09-11 2021-04-29 Ambrx Inc Interleukin-2 polypeptide conjugates and their uses
WO2020060944A1 (en) 2018-09-17 2020-03-26 Sutro Biopharma, Inc. Combination therapies with anti-folate receptor antibody conjugates
EP3867265A1 (en) 2018-10-19 2021-08-25 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
JP2022520792A (en) 2019-02-12 2022-04-01 アンブルックス,インコーポレイテッド Compositions, Methods, and Uses Containing Antibody-TLR Agonist Conjugates
EP3962951A1 (en) 2019-05-03 2022-03-09 Sutro Biopharma, Inc. Anti-bcma antibody conjugates
CN114269749A (en) 2019-06-10 2022-04-01 苏特罗生物制药公司 5H-pyrrolo [3,2-d ] pyrimidine-2, 4-diamino compounds and antibody conjugates thereof
EP3983410A1 (en) 2019-06-17 2022-04-20 Sutro Biopharma, Inc. 1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis
EP4114852A1 (en) 2020-03-03 2023-01-11 Sutro Biopharma, Inc. Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
IL296099A (en) 2020-03-11 2022-11-01 Ambrx Inc Interleukin-2 polypeptide conjugates and methods of use thereof
WO2022040596A1 (en) 2020-08-20 2022-02-24 Ambrx, Inc. Antibody-tlr agonist conjugates, methods and uses thereof
WO2022103983A2 (en) 2020-11-11 2022-05-19 Sutro Biopharma, Inc. Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof, and methods for their use
IL307282A (en) 2021-04-03 2023-11-01 Ambrx Inc Anti-her2 antibody-drug conjugates and uses thereof
WO2022232488A1 (en) 2021-04-30 2022-11-03 Celgene Corporation Combination therapies using an anti-bcma antibody drug conjugate (adc) in combination with a gamma secretase inhibitor (gsi)
WO2024006272A1 (en) 2022-06-27 2024-01-04 Sutro Biopharma, Inc. β-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF
US20240058465A1 (en) 2022-06-30 2024-02-22 Sutro Biopharma, Inc. Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates
WO2024015229A1 (en) 2022-07-15 2024-01-18 Sutro Biopharma, Inc. Protease/enzyme cleavable linker-payloads and protein conjugates
WO2024044780A1 (en) 2022-08-26 2024-02-29 Sutro Biopharma, Inc. Interleukin-18 variants and uses thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4694064A (en) 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
EP0271180A1 (en) 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US4857599A (en) * 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
US4871779A (en) 1985-12-23 1989-10-03 The Dow Chemical Company Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
US5041516A (en) * 1989-06-21 1991-08-20 Cornell Research Foundation, Inc. Dendritic molecules and method of production
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969436A (en) * 1972-08-18 1976-07-13 Ceskoslovenska Akademie Ved Carriers for biologically active compounds and methods for the production thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4871779A (en) 1985-12-23 1989-10-03 The Dow Chemical Company Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
US4694064A (en) 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
EP0271180A1 (en) 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US4857599A (en) * 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
US5041516A (en) * 1989-06-21 1991-08-20 Cornell Research Foundation, Inc. Dendritic molecules and method of production

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Aharoni et al., "Size and Solution Properties of Globular tert-Butyloxycarbonyl-poly(∝, epsilon-L-lysine)", Marcromolecules, 15, 1093, (1982).
Flory, "Molecular Size Distribution in three Dimensional Polymers", J. Am. Chem Soc., 74, 2719 (1952).
Newkome et al., "Cascade Molecules: Synthesis and Characterization . . . ", J. Am. Chem Soc., 108, 849, (1986).
Newkome et al., "Cascade Molucules: A New Approach to Micelles", J. Am. Chem Soc., 50, 2003 (1985).
Newkome et al., "Two-Directional Cascade Molecules . . . ", J. Am. Chem Soc., 752, (1986).
Polymer Preprints, V 32, No 3, Aug. 1991 pp. 629-632. *
Vogtle et al., '"Cascad' and 'Nonskid-Chain-like' Syntheses of Molecular Cavity Topologies", Synthesis, 155, (Feb. 1978).

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277664B2 (en) * 2008-10-03 2012-10-02 California Institute Of Technology Extraction of anions from solutions and mixtures using hyperbranched macromolecules
US20100181257A1 (en) * 2008-10-03 2010-07-22 Jean Frechet Extraction Of Anions From Solutions And Mixtures Using Hyperbranched Macromolecules
US9815712B2 (en) 2008-10-03 2017-11-14 California Institute Of Technology High capacity perchlorate-selective resins from hyperbranched macromolecules
US9249275B2 (en) 2009-07-01 2016-02-02 Japan Science And Technology Agency Polyionic dendrimer and hydrogel comprising same
US8658702B2 (en) 2009-12-17 2014-02-25 Mamadou Diallo Soluble anion exchangers from hyperbranched macromolecules
US10081705B2 (en) 2012-03-13 2018-09-25 California Institute Of Technology Periodic nanostructures from self assembled wedge-type block-copolymers
US9045579B2 (en) 2012-03-13 2015-06-02 California Institute Of Technology Periodic nanostructures from self assembled wedge-type block-copolymers
US9382387B2 (en) 2012-03-13 2016-07-05 California Institute Of Technology Rapid self-assembly of block copolymers to photonic crystals
US10732321B2 (en) 2012-06-28 2020-08-04 California Institute Of Technology Photonic structures from self assembly of brush block copolymers and polymer blends
US9453943B2 (en) 2012-06-28 2016-09-27 California Institute Of Technology Photonic structures from self assembly of brush block copolymers and polymer blends
US20150118624A1 (en) * 2013-10-24 2015-04-30 Az Electronic Materials (Luxembourg) S.A.R.L. Composition for forming resist underlayer
US9328198B2 (en) * 2013-10-24 2016-05-03 Az Electronic Materials (Luxembourg) S.A.R.L. Composition for forming resist underlayer
US10153513B2 (en) 2015-03-09 2018-12-11 California Institute Of Technology Triblock brush block copolymers
US10608280B2 (en) 2015-03-09 2020-03-31 California Institute Of Technology Brush block copolymer electrolytes and electrocatalyst compositions
US11053356B2 (en) 2017-03-07 2021-07-06 California Institute Of Technology Control of polymer architectures by living ring-opening metathesis copolymerization

Also Published As

Publication number Publication date
WO1993021259A1 (en) 1993-10-28
JPH07505915A (en) 1995-06-29
EP0636156B1 (en) 1997-07-30
EP0636156A1 (en) 1995-02-01
DE69312700T2 (en) 1998-02-19
CA2118130A1 (en) 1993-10-28
ATE156158T1 (en) 1997-08-15
DE69312700D1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
US7101937B1 (en) Dendritic based macromolecules
US5925720A (en) Heterotelechelic block copolymers and process for producing the same
US5514764A (en) Hyperbranched polyesters and polyamides
Jikei et al. Hyperbranched polymers: a promising new class of materials
Carlmark et al. New methodologies in the construction of dendritic materials
AU741166B2 (en) Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
US7960479B2 (en) Brush copolymers
Cammas et al. Heterobifunctional Poly (ethylene oxide): Synthesis of. alpha.-Methoxy-. omega.-amino and. alpha.-Hydroxy-. omega.-amino PEOs with the Same Molecular Weights
US4847328A (en) Hybrid acrylic star polymers
KR910009115B1 (en) Hybrid acrylic star polymers
Lach et al. Hyperbranched carbosilane oxazoline‐macromonomers: polymerization and coupling to a trimesic acid core
Bandyopadhyay et al. Hyperbranched polymers for biomedical applications
US7425593B2 (en) Amphiphilic triblock copolymers comprising poly(2-vinylpyridine) block and poly(alkyl isocyanate) block, and the preparation method thereof
US6184313B1 (en) Hybrid silane dendrimer-star polymers
US6632889B1 (en) Convergent self-branching polymerization
US4851477A (en) Hybrid acrylic-condensation star polymers by group transfer polymerization
US6525170B1 (en) Highly branched polyesters through one-step polymerization process
US7009033B2 (en) Heterofunctional polyethylene glycol and polyethylene oxide, process for their manufacture
US20050038197A1 (en) Ultra_high molecular weight hybrid dendrigraft architectures
Dvornic et al. Nanostructured materials from radially layered copolymeric amidoamine-organosilicon (PAMAMOS) dendrimers
Malenfant et al. Hybridization of Architectural States: Dendritic‐Linear Copolymer Hybrids
Saboktakin et al. Synthesis and characterization of aromatic polyether dendrimer/poly (2-hydroxyethyl methacrylate) copolymer as nano drug carriers
Six et al. Dendritic Architectures by the Convergent Method
Gong Linear, branched and crosslinked polyesters, polyurethanes and polymethacrylates derived from rotaxane formation: Syntheses and properties
WO2003072636A1 (en) Cationic highly branched polyaminoester

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20100905